Jerome Wilson, MA, Ph.D, is Senior Scientific Affairs Director at Pra International, Late Phase Services, USA.
Jerome Wilson and Martin Nemansky, explore some of the difficulties of implementing biomarkers during drug development.
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
Sponsored By Oracle
Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements
Sponsored By UBC Express Scripts
Overcoming the Life Sciences Content Conundrum in a Multichannel World
Sponsored By Veeva